7 unchanged sentences
made about certain clinical trials for ANAVEX ® 2-73.
−Removed: The Company believes the complaint is without merit.
−Removed: The Company is
−Removed: vigorously pursuing its defenses and a potential dismissal of all claims asserted in the lawsuit.
+Added: On July 12, 2024, the lead plaintiff filed an amended complaint.
+Added: Company believes the complaint is without merit.
+Added: The Company is vigorously pursuing its defenses and a potential dismissal of all claims
+Added: asserted in the lawsuit.
+Added: On May 8, 2024,
+Added: another purported shareholder of the Company filed a similar lawsuit against the same defendants that raised similar allegations and in
+Added: addition, raised allegations related to disclosures and statements made about the AVATAR trial.
+Added: The shareholder sought to consolidate
+Added: the cases and be appointed lead plaintiff of the consolidated action.
+Added: The court denied the consolidation motion and lead plaintiff motion
+Added: on June 13, 2024.
+Added: The Company plans to vigorously defend the lawsuit.
+Added: On May 13, 2024,
+Added: a purported shareholder filed a derivative lawsuit on behalf of the Company against the board of directors.
+Added: The complaint asserts various
+Added: common law claims (including breach of fiduciary duty) and violation of Section 14(a) regarding the same allegations at issue in the two
+Added: purported class action lawsuits related to disclosures and statements made about certain clinical trials.
+Added: The Company is named as a Nominal
+Added: The defendants plan to vigorously defend the lawsuit.
know of no other material pending legal or governmental proceedings, other than ordinary routine litigation incidental to our business,
7 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.